GRANULESPharmaceuticals

Granules India LtdCash Flow Statement

620.40
-0.75%

Granules India Ltd Cash Flow Statement (Annual)

Metric20252024202320222021
Free Cash Flow294.87 Cr58.84 Cr328.07 Cr-65.65 Cr
Repayment Of Debt-2.34K Cr-1.82K Cr-2.08K Cr-95.48 Cr
Issuance Of Debt2.40K Cr1.97K Cr2.03K Cr348.52 Cr
Issuance Of Capital Stock5.00 Cr3.16 Cr2.78 Cr3.71 Cr
Capital Expenditure-571.69 Cr-380.58 Cr-410.68 Cr-397.71 Cr
End Cash Position466.11 Cr381.10 Cr291.56 Cr184.71 Cr
Beginning Cash Position381.10 Cr291.56 Cr184.71 Cr41.84 Cr
Effect Of Exchange Rate Changes2.24 Cr2.63 Cr-0.25 Cr0.94 Cr
Changes In Cash82.77 Cr86.92 Cr107.10 Cr141.94 Cr
Financing Cash Flow-92.51 Cr7.66 Cr-440.29 Cr190.00 Cr
Interest Paid Cff-103.46 Cr-102.67 Cr-53.27 Cr-24.18 Cr
Cash Dividends Paid-36.35 Cr-36.31 Cr-18.62 Cr-37.17 Cr
Common Stock Dividend Paid-36.35 Cr-36.31 Cr-18.62 Cr-37.17 Cr
Net Common Stock Issuance5.00 Cr3.16 Cr-307.87 Cr3.71 Cr
Common Stock Issuance5.00 Cr3.16 Cr2.78 Cr3.71 Cr
Net Issuance Payments Of Debt60.09 Cr154.78 Cr-47.09 Cr253.04 Cr
Net Short Term Debt Issuance-133.95 Cr237.50 Cr45.99 Cr348.52 Cr
Short Term Debt Payments-2.24K Cr-1.71K Cr-1.98K Cr
Short Term Debt Issuance2.11K Cr1.95K Cr2.03K Cr348.52 Cr
Net Long Term Debt Issuance194.03 Cr-82.72 Cr-93.09 Cr-95.48 Cr
Long Term Debt Payments-99.79 Cr-101.68 Cr-93.09 Cr-95.48 Cr
Long Term Debt Issuance293.83 Cr18.96 Cr0.00
Investing Cash Flow-691.29 Cr-360.16 Cr-191.36 Cr-380.12 Cr
Interest Received Cfi3.60 Cr2.77 Cr5.05 Cr12.14 Cr
Net Investment Purchase And Sale-124.89 Cr15.89 Cr203.48 Cr4.48 Cr
Sale Of Investment0.01 Cr15.89 Cr203.48 Cr4.48 Cr
Purchase Of Investment-124.91 Cr0.00-131.39 Cr
Net PPE Purchase And Sale-569.99 Cr-378.83 Cr-410.46 Cr-396.73 Cr
Sale Of PPE1.70 Cr1.75 Cr0.21 Cr0.98 Cr
Purchase Of PPE-571.69 Cr-380.58 Cr-410.68 Cr-397.71 Cr
Operating Cash Flow866.57 Cr439.41 Cr738.75 Cr332.06 Cr
Taxes Refund Paid-143.75 Cr-190.30 Cr-175.80 Cr-145.05 Cr
Change In Working Capital6.02 Cr-246.32 Cr-10.31 Cr-257.19 Cr
Change In Other Current Assets-13.02 Cr-71.02 Cr16.07 Cr-16.01 Cr
Change In Payable3.72 Cr-3.87 Cr109.17 Cr73.97 Cr
Change In Inventory-20.57 Cr-140.73 Cr-135.47 Cr-184.03 Cr
Change In Receivables35.88 Cr-30.70 Cr-0.08 Cr-131.13 Cr
Other Non Cash Items99.50 Cr103.02 Cr51.42 Cr10.36 Cr
Stock Based Compensation-5.70 Cr0.28 Cr1.29 Cr1.62 Cr
Provisionand Write Offof Assets0.33 Cr0.000.93 Cr1.65 Cr
Depreciation And Amortization225.50 Cr207.33 Cr184.49 Cr158.63 Cr
Depreciation225.50 Cr207.33 Cr142.95 Cr122.25 Cr
Gain Loss On Investment Securities10.87 Cr16.11 Cr7.29 Cr11.21 Cr
Net Foreign Currency Exchange Gain Loss4.50 Cr-7.74 Cr-9.15 Cr-11.97 Cr
Gain Loss On Sale Of PPE2.49 Cr2.32 Cr1.37 Cr4.78 Cr
Net Income From Continuing Operations660.17 Cr547.23 Cr687.17 Cr558.00 Cr
Repurchase Of Capital Stock0.00-310.65 Cr0.00-177.14 Cr
Common Stock Payments0.00-310.65 Cr0.00-177.14 Cr
Amortization Cash Flow47.00 Cr41.54 Cr36.38 Cr35.92 Cr
Net Other Financing Charges-0.50 Cr
Net Business Purchase And Sale-90.00 Cr0.00109.85 Cr
Purchase Of Business-90.00 Cr-5.00 Cr
Sale Of Business0.00109.85 Cr
Gain Loss On Sale Of Business0.00

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.